Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
NEW YORK, June 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global interventional neurology market. The report provides market landscape, competitive landscape and market trends information on the interventional neurology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Embolic Systems, Navigational Systems, Neurovascular Stents and Aneurysm Clips.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within interventional neurology market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Boston Scientific Corporation, Johnson & Johnson, Covidien plc and Terumo Corporation.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the interventional neurology market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the interventional neurology market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global interventional neurology market and the factors shaping it.
1 Table of contents
1 Table of contents 3
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction and Overview 9
2.1 Introduction 9
2.2 GlobalData Report Guidance 9
3 Interventional Neurology: Overview 10
3.1 Interventional Neurology: Market Segmentation 10
3.1.1 Embolic systems 11
3.1.2 Navigational Systems 11
3.1.3 Neurovascular Stents 12
3.1.4 Aneurysm Clips 12
4 Aneurysms: Overview 13
4.1 Cerebral Aneurysm 13
4.1.1 Types of Cerebral Aneurysm 13
4.1.2 Causes 14
4.1.3 Pathophysiology 14
4.1.4 Epidemiology 15
4.1.5 Diagnosis 15
5 Interventional Neurology: Global Market Characterization 16
5.1 Interventional Neurology Market, Global, Revenue ($m), Historic, 2003-2010 16
5.2 Interventional Neurology Market, Global, Revenue ($m), Forecast, 2010-2017 17
5.3 Interventional Neurology Market, Key Trends 18
5.3.1 Use of Interventional Neurology Products for Treating Other Diseases is a Emerging Trend in the Market 18
5.3.2 Neuroform Stents 19
5.3.3 Liquid Embolic Systems 19
5.3.4 Acquisitions of Major Interventional Neurology Companies 20
5.4 Interventional Neurology, Market Dynamics 21
5.4.1 Market Drivers 21
5.4.2 Interventional Neurology, Market Restraints 23
6 Interventional Neurology Market, Analysis by Segment 25
6.1 Embolic Systems, Market Characterization 25
6.1.1 Embolic Systems Market, Global, Revenue ($m), Historic, 2003-2010 25
6.1.2 Embolic Systems Market, Global, Revenue ($m), Forecast, 2010-2017 26
6.2 Embolic Systems: Market Dynamics 27
6.2.1 Market Drivers 27
6.2.2 Market Restraint 27
6.3 Navigational Systems: Market Characterization 28
6.3.1 Navigational Systems Market, Global, Revenue ($m), Historic, 2003-2010 28
6.3.2 Navigational Systems Market, Global, Revenue ($m), Forecast, 2010-2017 29
6.4 Navigational Systems: Market Dynamics 30
6.4.1 Market Drivers 30
6.4.2 Market Restraint: 30
6.5 Neurovascular Stents: Market Characterization 31
6.5.1 Neurovascular Stents Market, Global, Revenue ($m), Historic, 2003-2010 31
6.5.2 Neurovascular Stents Market, Global, Revenue ($m), Forecast, 2010-2017 32
6.6 Neurovascular Stents: Market Dynamics 33
6.6.1 Market Driver: Technological Advancements is to Drive the Market 33
6.6.2 Market Restraint: High Risk associated with Stent to Restrain the Market 33
6.7 Aneurysm Clips: Market Characterization 34
6.7.1 Aneurysm Clips Market, Global, Revenue ($m), Historic, 2003-2010 34
6.7.2 Aneurysm Clips Market, Global, Revenue ($m), Forecast, 2010-2017 35
6.8 Aneurysm Clips: Market Dynamics 36
6.8.1 Market Driver: Cost of Treatment Is Driving the Market 36
6.8.2 Market Restraint: Advancements in the Treatment of Aneurysms is a Restraint to the Clipping Market 36
7 Interventional Neurology Market, by Country, Revenue ($m), 2003-2017 37
7.1 Interventional Neurology Market, The US, Revenue ($m), Historic, 2003-2010 37
7.2 Interventional Neurology Market, The US, Revenue ($m), Forecast, 2010-2017 38
7.3 Interventional Neurology Market, Canada, Revenue ($m), Historic, 2003-2010 39
7.4 Interventional Neurology Market, Canada, Revenue ($m), Forecast, 2003-2010 40
7.5 Interventional Neurology Market, The UK, Revenue ($m), Historic, 2003-2010 41
7.6 Interventional Neurology Market, The UK, Revenue ($m), Forecast, 2010-2017 42
7.7 Interventional Neurology Market, Germany, Revenue ($m), Historic, 2003-2010 43
7.8 Interventional Neurology Market, Germany, Revenue ($m), Forecast, 2010-2017 44
7.9 Interventional Neurology Market, France, Revenue ($m), Historic, 2003-2010 45
7.10 Interventional Neurology Market, France, Revenue ($m), Forecast, 2010-2017 46
7.11 Interventional Neurology Market, Italy, Revenue ($m), Historic, 2003-2010 47
7.12 Interventional Neurology Market, Italy, Revenue ($m), Forecast, 2010-2017 48
7.13 Interventional Neurology Market, Spain, Revenue ($m), Historic, 2003-2010 49
7.14 Interventional Neurology Market, Spain, Revenue ($m), Forecast, 2010-2017 50
7.15 Interventional Neurology Market, Japan, Revenue ($m), Historic, 2003-2010 51
7.16 Interventional Neurology Market, Japan, Revenue ($m), Forecast, 2010-2017 52
7.17 Interventional Neurology Market, China, Revenue ($m), Historic, 2003-2010 53
7.18 Interventional Neurology Market, China, Revenue ($m), Forecast, 2010-2017 54
7.19 Interventional Neurology Market, India, Revenue ($m), Historic, 2003-2010 55
7.20 Interventional Neurology Market, India, Revenue ($m), Forecast, 2010-2017 56
7.21 Interventional Neurology Market, Australia, Revenue ($m), Historic, 2003-2010 57
7.22 Interventional Neurology Market, Australia, Revenue ($m), Forecast, 2010-2017 58
7.23 Interventional Neurology Market, Brazil, Revenue ($m), Historic, 2003-2010 59
7.24 Interventional Neurology Market, Brazil, Revenue ($m), Forecast, 2010-2017 60
8 Interventional Neurology Market: Strategic Competitive Assessment 61
8.1 Interventional Neurology: Key Market Participants 62
8.1.1 Boston Scientific Corporation 62
8.1.2 Johnson & Johnson 65
8.1.3 Covidien plc 68
8.1.4 Terumo Corporation 71
9 Interventional Neurology: Key Marketed Products 74
9.1 Neuroform3 Microdelivery Stent System 74
9.1.1 Product Description 74
9.1.2 Features and Benefits 74
9.2 Axium Detachable Coil System 74
9.2.1 Product Description 74
9.2.2 Features and Benefits 74
9.3 Onyx HD-500 75
9.3.1 Product Description 75
9.3.2 Features and Benefits 75
9.4 AZUR Peripheral HydroCoil Embolization System 75
9.4.1 Product Description 75
9.4.2 Features and Benefits 75
9.5 DELTAPAQ Microcoils 76
9.5.1 Product Description 76
9.5.2 Features and Benefits 76
10 Interventional Neurology Market: Strategic Pipeline Assessment 77
10.1 Interventional Neurology Products under Clinical Development 78
10.1.1 GORE Embolic Filter 78
10.1.2 Restore Microcatheter 79
10.1.3 PHAROS Vitesse Stent 80
10.1.4 Neucrylate AN 83
10.1.5 Solitaire FR Revascularization Device 84
10.1.6 Solitaire AB Neurovascular Remodeling Device 88
10.1.7 Transcranial Doppler Ultrasound Device 88
10.2 Interventional Neurology Products under Early Development 88
10.2.1 AIC Catheter 89
10.2.2 Balloon Expandable Stent - Next Generation 89
10.2.3 Catheter Based System 89
10.2.4 Covered Stent 89
10.2.5 Flow Diverter 89
10.2.6 Liquid Embolic System 89
10.2.7 Neuravi Device 89
10.2.8 Occlusion Balloons 89
10.2.9 Self-Expanding Stent 90
10.2.10 TBI Intervention System 90
10.3 Interventional Neurology Products under Pre-Clinical Development 90
10.3.1 Aneurysm Occlusion Device 90
10.3.2 Brain Cooling Device 90
10.3.3 Cerebral Aneurysm Repair Device 90
10.3.4 GP Mechanical Thrombectomy Device 90
10.3.5 NAVIMAX Spiral Balloon Catheter 90
10.3.6 Ultrasound Clot Buster 91
10.4 Interventional Neurology Products in Approval Phase 91
10.4.1 MicruSphere Microcoil 91
10.4.2 Cerecyte Microcoil 93
10.4.3 NeuroFlo Catheter 98
10.4.4 X Calibur Aneurysm Occlusion Device 110
10.4.5 Neucrylate AN 111
10.4.6 Courier Microcatheter 112
10.4.7 HeliPaq 112
10.4.8 HeliPaq SR 112
10.4.9 InterPaq Microcoil 112
10.4.10 UltiPaq Microcoil 112
11 Interventional Neurology Market: Strategic Deals Analysis 113
11.1 Key Acqusitions 114
11.1.1 Stryker Acquires Boston Scientifics' Neurovascular Division 114
11.1.2 Johnson & Johnson Acquires Micrus Endovascular 114
11.1.3 Covidien Completed Acquisition of ev3 for $2.6 Billion 115
12 Appendix 116
12.1 Definitions 117
12.1.1 Interventional Neurology 117
12.1.2 Embolic Systems 117
12.1.3 Navigational Systems 117
12.1.4 Neurovascular Stents 117
12.1.5 Aneurysm Clips 117
12.2 Acronyms 118
12.3 Sources 118
12.4 Research Methodology 119
12.5 Secondary Research 119
12.6 Primary Research 119
12.7 Models 120
12.8 Forecasts 120
12.9 GlobalData Consulting 120
12.10 Contact Us 121
12.11 Disclaimer 121
1.1 List of Tables
Table 1: Interventional Neurology Market, Global, Revenue ($m), 2003-2010 16
Table 2: Interventional Neurology Market, Global, Revenue ($m), 2010-2017 17
Table 3: Major Acquisitions in Interventional Neurology Market 20
Table 4: Embolic Systems Market, Global, Revenue ($m), 2003-2010 25
Table 5: Embolic Systems Market, Global, Revenue ($m), 2010-2017 26
Table 6: Navigational Systems Market, Global, Revenue ($m), 2003-2010 28
Table 7: Navigational Systems Market, Global, Revenue ($m), 2010-2017 29
Table 8: Neurovascular Stents Market, Revenue ($m), 2003-2010 31
Table 9: Neurovascular Stents Market, Revenue ($m), 2010-2017 32
Table 10: Aneurysm Clips Market, Global, Revenue ($m), 2003-2010 34
Table 11: Aneurysm Clips Market, Global, Revenue ($m), 2010-2017 35
Table 12: Interventional Neurology Market, The US, Revenue ($m), 2003-2010 37
Table 13: Interventional Neurology Market, The US, Revenue ($m), 2010-2017 38
Table 14: Interventional Neurology Market, Canada, Revenue ($m), 2003-2010 39
Table 15: Interventional Neurology Market, Canada, Revenue ($m), 2010-2017 40
Table 16: Interventional Neurology Market, the UK, Revenue ($m), 2003-2010 41
Table 17: Interventional Neurology Market, The UK, Revenue ($m), 2010-2017 42
Table 18: Interventional Neurology Market, Germany, Revenue ($m), 2003-2010 43
Table 19: Interventional Neurology Market, Germany, Revenue ($m), 2010-2017 44
Table 20: Interventional Neurology Market, France, Revenue ($m), 2003-2010 45
Table 21: Interventional Neurology Market, France, Revenue ($m), 2010-2017 46
Table 22: Interventional Neurology Market, Italy, Revenue ($m), 2003-2010 47
Table 23: Interventional Neurology Market, Italy, Revenue ($m), 2010-2017 48
Table 24: Interventional Neurology Market, Spain, Revenue ($m), 2003-2010 49
Table 25: Interventional Neurology Market, Spain, Revenue ($m), 2010-2017 50
Table 26: Interventional Neurology Market, Japan, Revenue ($m), 2003-2010 51
Table 27: Interventional Neurology Market, Japan, Revenue ($m), 2010-2017 52
Table 28: Interventional Neurology Market, China, Revenue ($m), 2003-2010 53
Table 29: Interventional Neurology Market, China, Revenue ($m), 2010-2017 54
Table 30: Interventional Neurology Market, India, Revenue ($m), 2003-2010 55
Table 31: Interventional Neurology Market, India, Revenue ($m), 2010-2017 56
Table 32: Interventional Neurology Market, Australia, Revenue ($m), 2003-2010 57
Table 33: Interventional Neurology Market, Australia, Revenue ($m), 2010-2017 58
Table 34: Interventional Neurology Market, Brazil, Revenue ($m), 2003-2010 59
Table 35: Interventional Neurology Market, Brazil, Revenue ($m), 2010-2017 60
Table 36: Interventional Neurology Market, Company Share (%), 2010 61
Table 37: Boston Scientific Corporation, Marketed Products 62
Table 38: Johnson and Johnson, Marketed Products 65
Table 39: Johnson & Johnson, Pipeline Products 66
Table 40: Covidien, Inc, Marketed Products 68
Table 41: Covidien, Inc, Pipeline Products 68
Table 42: Terumo Corporation, Marketed Products 71
Table 43: Neuroform Microdelivery Stent System, Features and Benefits 74
Table 44: Axium Detachable Coil System, Features and Benefits 74
Table 45: Onyx HD-500, Features and Benefits 75
Table 46: AZUR Peripheral HydroCoil Embolization System, Features and Benefits 75
Table 47: DELTAPAQ Microcoils, Features and Benefits 76
Table 48: Interventional Neurology, Products Under Clinical Development, 2011 78
Table 49: GORE Embolic Filter, Product Status, 2011 78
Table 50: GORE Embolic Filter, Clinical Trials, 2011 79
Table 51: Restore Microcatheter, Product Status, 2011 79
Table 52: Restore Microcatheter, Clinical Trial, 2011 80
Table 53: PHAROS Vitesse Stent, Product Status, 2011 80
Table 54: PHAROS Vitesse Stent, Clinical Trial, 2011 81
Table 55: Neucrylate AN, Product Status, 2011 83
Table 56: Neucrylate AN, Clinical Trial, 2011 83
Table 57: Solitaire FR Revascularization Device, Product Status, 2011 84
Table 58: Solitaire FR Revascularization Device, Clinical Trial (0), 2011 85
Table 59: Solitaire FR Revascularization Device, Clinical Trial (1), 2011 86
Table 60: Interventional Neurology, Products Under Early Development, 2011 88
Table 61: Interventional Neurology, Products Under Pre-Clinical Development, 2011 90
Table 62: Interventional Neurology, Products in Approval Phase, 2011 91
Table 63: MicruSphere Microcoil, Product Status, 2011 91
Table 64: MicruSphere Microcoil, Clinical Trials, 2011 92
Table 65: Cerecyte Microcoil, Clinical Trial(0), 2011 93
Table 66: Cerecyte Microcoil, Clinical Trial(1), 2011 94
Table 67: Cerecyte Microcoil, Clinical Trial(2), 2011 95
Table 68: Cerecyte Microcoil, Clinical Trial(3), 2011 96
Table 69: Cerecyte Microcoil, Clinical Trial(4), 2011 97
Table 70: NeuroFlo Catheter, Product Status, 2011 98
Table 71: NeuroFlo Catheter, Clinical Trial (0), 2011 99
Table 72: NeuroFlo Catheter, Clinical Trial (1), 2011 100
Table 73: NeuroFlo Catheter, Clinical Trial (2), 2011 101
Table 74: NeuroFlo Catheter, Clinical Trial (3), 2011 103
Table 75: NeuroFlo Catheter, Clinical Trial (4), 2011 104
Table 76: NeuroFlo Catheter, Clinical Trial (5), 2011 106
Table 77: NeuroFlo Catheter, Clinical Trial (6), 2011 107
Table 78: NeuroFlo Catheter, Clinical Trial (7), 2011 108
Table 79: NeuroFlo Catheter, Clinical Trial (8), 2011 109
Table 80: X Calibur Aneurysm Occlusion Device, Product Status, 2011 110
Table 81: X Calibur Aneurysm Occlusion Device, Clinical Trials, 2011 111
Table 82: Neucrylate AN, Product Status, 2011 111
Table 83: Interventional Neurology Market, Deal Value ($m) and Volume, 2004 – 2010 113
1.2 List of Figures
Figure 1: Interventional Neurology, Market Segmentation 10
Figure 2: Embolization Coils Procedure 11
Figure 3: Aneurysm Clipping Procedure 12
Figure 4: Types of Cerebral Aneurysms 13
Figure 5: Cerebral Aneurysm, Pathophysiology 14
Figure 6: Cerebral Aneurysm, Disease Burden, 2008 15
Figure 7: Interventional Neurology Market, Global, Revenue ($m), 2003-2010 16
Figure 8: Interventional Neurology Market, Global, Revenue ($m), 2010-2017 17
Figure 9: Interventional Neurology Treatment, by Disease 18
Figure 10: Interventional Neurology, Market Dynamics 21
Figure 11: Embolic Systems Market, Global, Revenue ($m), 2003-2010 25
Figure 12: Embolic Systems Market, Global, Revenue ($m), 2010-2017 26
Figure 13: Navigational Systems Market, Global, Revenue ($m), 2003-2010 28
Figure 14: Navigational Systems Market, Global, Revenue ($m), 2010-2017 29
Figure 15: Neurovascular Stents Market, Revenue ($m), 2003-2010 31
Figure 16: Neurovascular Stents Market, Revenue ($m), 2010-2017 32
Figure 17: Aneurysm Clips Market, Global, Revenue ($m), 2003-2010 34
Figure 18: Aneurysm Clips Market, Global, Revenue ($m), 2010-2017 35
Figure 19: Interventional Neurology Market, The US, Revenue ($m), 2003-2010 37
Figure 20: Interventional Neurology Market, The US, Revenue ($m), 2010-2017 38
Figure 21: Interventional Neurology Market, Canada, Revenue ($m), 2003-2010 39
Figure 22: Interventional Neurology Market, Canada, Revenue ($m), 2010-2017 40
Figure 23: Interventional Neurology Market, The UK, Revenue ($m), 2003-2010 41
Figure 24: Interventional Neurology Market, The UK, Revenue ($m), 2010-2017 42
Figure 25: Interventional Neurology Market, Germany, Revenue ($m), 2003-2010 43
Figure 26: Interventional Neurology Market, Germany, Revenue ($m), 2010-2017 44
Figure 27: Interventional Neurology Market, France, Revenue ($m), 2003-2010 45
Figure 28: Interventional Neurology Market, France, Revenue ($m), 2010-2017 46
Figure 29: Interventional Neurology Market, Italy, Revenue ($m), 2003-2010 47
Figure 30: Interventional Neurology Market, Italy, Revenue ($m), 2010-2017 48
Figure 31: Interventional Neurology Market, Spain, Revenue ($m), 2003-2010 49
Figure 32: Interventional Neurology Market, Spain, Revenue ($m), 2010-2017 50
Figure 33: Interventional Neurology Market, Japan, Revenue ($m), 2003-2010 51
Figure 34: Interventional Neurology Market, Japan, Revenue ($m), 2010-2017 52
Figure 35: Interventional Neurology Market, China, Revenue ($m), 2003-2010 53
Figure 36: Interventional Neurology Market, China, Revenue ($m), 2010-2017 54
Figure 37: Interventional Neurology Market, India, Revenue ($m), 2003-2010 55
Figure 38: Interventional Neurology Market, India, Revenue ($m), 2010-2017 56
Figure 39: Interventional Neurology Market, Australia, Revenue ($m), 2003-2010 57
Figure 40: Interventional Neurology Market, Australia, Revenue ($m), 2010-2017 58
Figure 41: Interventional Neurology Market, Brazil, Revenue ($m), 2003-2010 59
Figure 42: Interventional Neurology Market, Brazil, Revenue ($m), 2010-2017 60
Figure 43: Interventional Neurology Market, Company Share (%), 2010 61
Figure 44: Boston Scientific, SWOT Analysis 63
Figure 45: Johnson & Johnson, SWOT Analysis 66
Figure 46: Covidien, Inc, SWOT Analysis 69
Figure 47: Terumo Corporation, SWOT Analysis 72
Figure 48: Interventional Neurology Market, Global Pipeline Products 77
Figure 49: Interventional Neurology Market, Deal Value ($m) and Volume, 2004 – 2010 113
Companies Mentioned
Boston Scientific Corporation
Johnson & Johnson
Covidien plc
Terumo Corporation
To order this report:
General Medicine and Specialty Medicine Industry: Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
General Medicine and Specialty Medicine Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article